Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Simplexa COVID-19 & Flu A/B Direct

K-Number: K220963 · 2023-03-17

Decision Date2023-03-17
Product CodeQOF
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Simplexa COVID-19 & Flu A/B Direct is the device name listed in this FDA 510(k) record. The listed applicant is Diasorin Molecular, LLC. It received FDA 510(k) clearance on 2023-03-17 under 510(k) number K220963. The device is classified under product code QOF. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Simplexa COVID-19 & Flu A/B Direct?

Simplexa COVID-19 & Flu A/B Direct is a medical device that received FDA 510(k) clearance on 2023-03-17. The listed applicant is Diasorin Molecular, LLC. The 510(k) number is K220963.

When did Simplexa COVID-19 & Flu A/B Direct receive FDA 510(k) clearance?

Simplexa COVID-19 & Flu A/B Direct received FDA 510(k) clearance on 2023-03-17, under 510(k) number K220963.

Who is the listed applicant for Simplexa COVID-19 & Flu A/B Direct?

The FDA 510(k) record lists Diasorin Molecular, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Simplexa COVID-19 & Flu A/B Direct?

The FDA product code for Simplexa COVID-19 & Flu A/B Direct is QOF.

Other records listing Diasorin Molecular, LLC as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 13 devices →

Related Devices (Code: QOF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.